Chromosomal alterations in breast cancer revealed by multicolour fluorescence in situ hybridization - PubMed (original) (raw)
Chromosomal alterations in breast cancer revealed by multicolour fluorescence in situ hybridization
M B Watson et al. Int J Oncol. 2004 Aug.
Abstract
The aim of this study was to characterise cytogenetically, breast cancer cell lines and primary tumours to identify chromosomal regions of interest in breast cancer. Multicolour fluorescence in situ hybridization (MFISH) and comparative genomic hybridization (CGH) were used to karyotype five established breast cancer cell lines and two short-term primary tumour cultures. Chromosome 8 was identified as a frequent target for aberrations in all cell lines and one primary culture by MFISH and CGH. CGH identified frequent gains of 1q (all samples) and 14q (all cell lines) and deletion of 22q (all samples). MFISH revealed a t(9;17) translocation in both primary tumours and the T47D cell line. MFISH analysis of the cell lines revealed a significant number of translocations previously unidentified in other studies using similar techniques, highlighting the necessity of utilising data from both primary cultures and established cell lines when investigating complex cytogenetic aberrations using MFISH and CGH.
Similar articles
- Chromosomal alterations in small cell lung cancer revealed by multicolour fluorescence in situ hybridization.
Ashman JN, Brigham J, Cowen ME, Bahia H, Greenman J, Lind M, Cawkwell L. Ashman JN, et al. Int J Cancer. 2002 Nov 20;102(3):230-6. doi: 10.1002/ijc.10704. Int J Cancer. 2002. PMID: 12397641 - Multicolor fluorescence in situ hybridization and comparative genomic hybridization reveal molecular events in lung adenocarcinomas and squamous cell lung carcinomas.
Shen H, Gao W, Wu YJ, Qiu HR, Shu YQ. Shen H, et al. Biomed Pharmacother. 2009 Jul;63(6):396-403. doi: 10.1016/j.biopha.2008.08.010. Epub 2008 Sep 16. Biomed Pharmacother. 2009. PMID: 18848758 - Combined karyotyping, CGH and M-FISH analysis allows detailed characterization of unidentified chromosomal rearrangements in Merkel cell carcinoma.
Van Gele M, Leonard JH, Van Roy N, Van Limbergen H, Van Belle S, Cocquyt V, Salwen H, De Paepe A, Speleman F. Van Gele M, et al. Int J Cancer. 2002 Sep 10;101(2):137-45. doi: 10.1002/ijc.10591. Int J Cancer. 2002. PMID: 12209990 Review. - Molecular cytogenetic characterization of pancreas cancer cell lines reveals high complexity chromosomal alterations.
Griffin CA, Morsberger L, Hawkins AL, Haddadin M, Patel A, Ried T, Schrock E, Perlman EJ, Jaffee E. Griffin CA, et al. Cytogenet Genome Res. 2007;118(2-4):148-56. doi: 10.1159/000108295. Cytogenet Genome Res. 2007. PMID: 18000365 Review.
Cited by
- Immunogenic HER-2/neu peptides as tumor vaccines.
Baxevanis CN, Sotiriadou NN, Gritzapis AD, Sotiropoulou PA, Perez SA, Cacoullos NT, Papamichail M. Baxevanis CN, et al. Cancer Immunol Immunother. 2006 Jan;55(1):85-95. doi: 10.1007/s00262-005-0692-3. Epub 2005 Oct 27. Cancer Immunol Immunother. 2006. PMID: 15948002 Free PMC article. Review. - Genomic signatures of breast cancer metastasis.
Urquidi V, Goodison S. Urquidi V, et al. Cytogenet Genome Res. 2007;118(2-4):116-29. doi: 10.1159/000108292. Cytogenet Genome Res. 2007. PMID: 18000362 Free PMC article. - Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer.
Mironchik Y, Winnard PT Jr, Vesuna F, Kato Y, Wildes F, Pathak AP, Kominsky S, Artemov D, Bhujwalla Z, Van Diest P, Burger H, Glackin C, Raman V. Mironchik Y, et al. Cancer Res. 2005 Dec 1;65(23):10801-9. doi: 10.1158/0008-5472.CAN-05-0712. Cancer Res. 2005. PMID: 16322226 Free PMC article. - Comprehensive copy number profiles of breast cancer cell model genomes.
Shadeo A, Lam WL. Shadeo A, et al. Breast Cancer Res. 2006;8(1):R9. doi: 10.1186/bcr1370. Epub 2006 Jan 3. Breast Cancer Res. 2006. PMID: 16417655 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical